.jpg)
According to a story from Parkinson’s News Today, a study evaluating a pool of phase 3 clinical data confirmed the effectiveness of Gocovri, a drug
Huntington’s Disease Huntington’s disease (HD) is a rare neurodegenerative disease. It progressively affects the patient’s mobility and cognitive function. Unfortunately, a cure has yet to
According to a story from PR Newswire, the biopharmaceutical company Respivant Sciences has recently announced that it has dosed the first patient in its phase
According to a story from Acrofan, the biotechnology company Moderna, Inc. recently released the results of a preclinical study which described the use of mRNA
According to a story from globenewswire.com, the specialty pharmaceutical company Santhera Pharmaceuticals will be entering a collaborative partnership with the University of Basel’s Biozentrum. The
The International Waldenstrom’s Macroglobulinemia Foundation (IWMF) is a nonprofit organization founded by patients. Their mission? Support patients currently living with Waldenstrom’s Macroglobulinemia (WM) while simultaneously
© Copyright Patient Worthy
